TaiRx, Inc. 6580.TWO Stock
TaiRx, Inc. Price Chart
TaiRx, Inc. 6580.TWO Financial and Trading Overview
| TaiRx, Inc. stock price | 38.9 TWD |
| Previous Close | 35.75 TWD |
| Open | 34.95 TWD |
| Bid | 34.55 TWD x 0 |
| Ask | 34.95 TWD x 0 |
| Day's Range | 34.2 - 35.75 TWD |
| 52 Week Range | 27.9 - 53.1 TWD |
| Volume | 351.75K TWD |
| Avg. Volume | 104.09K TWD |
| Market Cap | 3.13B TWD |
| Beta (5Y Monthly) | 0.637328 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.31 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
6580.TWO Valuation Measures
| Enterprise Value | 2.88B TWD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 452.10745 |
| Price/Book (mrq) | 6.550878 |
| Enterprise Value/Revenue | 416.449 |
| Enterprise Value/EBITDA | -13.598 |
Trading Information
TaiRx, Inc. Stock Price History
| Beta (5Y Monthly) | 0.637328 |
| 52-Week Change | -0.42% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 53.1 TWD |
| 52 Week Low | 27.9 TWD |
| 50-Day Moving Average | 34 TWD |
| 200-Day Moving Average | 37.24 TWD |
6580.TWO Share Statistics
| Avg. Volume (3 month) | 104.09K TWD |
| Avg. Daily Volume (10-Days) | 126.68K TWD |
| Shares Outstanding | 90.2M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 850:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -3077.88% |
| Gross Margin | 57.08% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -21.46% |
| Return on Equity (ttm) | -36.63% |
Income Statement
| Revenue (ttm) | 6.92M TWD |
| Revenue Per Share (ttm) | 0.08 TWD |
| Quarterly Revenue Growth (yoy) | 22.60% |
| Gross Profit (ttm) | 3.95M TWD |
| EBITDA | -212028992 TWD |
| Net Income Avi to Common (ttm) | -211576992 TWD |
| Diluted EPS (ttm) | -2.51 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 358.28M TWD |
| Total Cash Per Share (mrq) | 3.97 TWD |
| Total Debt (mrq) | 15.38M TWD |
| Total Debt/Equity (mrq) | 3.21 TWD |
| Current Ratio (mrq) | 10.511 |
| Book Value Per Share (mrq) | 5.297 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -185664992 TWD |
| Levered Free Cash Flow (ttm) | -107813872 TWD |
Profile of TaiRx, Inc.
| Country | Taiwan |
| State | N/A |
| City | Taipei City |
| Address | No. 66, San-Chung Road |
| ZIP | 11502 |
| Phone | 886 2 2653 5007 |
| Website | https://www.trx.com.tw |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
TaiRx, Inc., a pharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of cancer and other diseases. The company's products under development include CVM-1118, an oral anti-cancer drug that is Phase II clinical trial; and Rexis, an add-on injection therapy that is in Phase III clinical trials to treat patients with sepsis. Its pre-clinical products comprise TRX-711 that is used to treat secondary hyperparathyroidism; TRX-920, an oral delivery formulation; and TRX-105, a molecule developed for treating and alleviating symptoms of various colitis. The company also offers Zelnite, a drug that helps in patient's blood Se level and immune system; and focuses on development of the nodal diagnostic devices and anti-body drugs. TaiRx, Inc. was founded in 2011 and is based in Taipei City, Taiwan.
Q&A For TaiRx, Inc. Stock
What is a current 6580.TWO stock price?
TaiRx, Inc. 6580.TWO stock price today per share is 38.9 TWD.
How to purchase TaiRx, Inc. stock?
You can buy 6580.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for TaiRx, Inc.?
The stock symbol or ticker of TaiRx, Inc. is 6580.TWO.
Which industry does the TaiRx, Inc. company belong to?
The TaiRx, Inc. industry is Biotechnology.
How many shares does TaiRx, Inc. have in circulation?
The max supply of TaiRx, Inc. shares is 110.2M.
What is TaiRx, Inc. Price to Earnings Ratio (PE Ratio)?
TaiRx, Inc. PE Ratio is now.
What was TaiRx, Inc. earnings per share over the trailing 12 months (TTM)?
TaiRx, Inc. EPS is -2.31 TWD over the trailing 12 months.
Which sector does the TaiRx, Inc. company belong to?
The TaiRx, Inc. sector is Healthcare.